ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001397144

Abingworth LLP

CIK 0001397144 Name as filed on the most recent filing

Filed as Abingworth LLP (25)

35 transaction lines · from 25 filings · filed 2011-03-02 to 2024-02-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

30 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-02-08 Jasper Therapeutics, Inc.
JSPR 		P, Open-market purchase 190,000 acquired 12.95 2,460,500.00 Form 4, filing 0000950170-24-014017
2023-01-27 Jasper Therapeutics, Inc.
JSPR 		P, Open-market purchase 3,133,333 acquired 1.50 4,699,999.50 Form 4, filing 0000899243-23-003059
2022-08-17 Vera Therapeutics, Inc.
VERA 		S, Open-market sale 6,472 disposed 20.42 132,158.89 Form 4, filing 0000899243-22-029282
2022-08-17 Vera Therapeutics, Inc.
VERA 		S, Open-market sale 3,281 disposed 19.88 65,242.36 Form 4, filing 0000899243-22-029282
2022-08-17 Vera Therapeutics, Inc.
VERA 		S, Open-market sale 172 disposed 21.07 3,624.87 Form 4, filing 0000899243-22-029282
2022-03-29 Soleno Therapeutics Inc
SLNO 		P, Open-market purchase 7,720,000 acquired Not reported Not priced Form 4, filing 0000905718-22-000523
2022-01-31 Sierra Oncology, Inc.
SRRA 		P, Open-market purchase 150,000 acquired 27.00 4,050,000.00 Form 4, filing 0000905718-22-000177
2021-05-18 Vera Therapeutics, Inc.
VERA 		P, Open-market purchase 772,727 acquired 11.00 8,499,997.00 Form 4, filing 0000905718-21-000712
2020-10-20 Personalis, Inc.
PSNL 		S, Open-market sale 130,486 disposed 27.66 3,609,242.76 Form 4, filing 0000905718-20-001059
2020-10-19 Personalis, Inc.
PSNL 		S, Open-market sale 196,423 disposed 27.86 5,472,344.78 Form 4, filing 0000905718-20-001057
2020-10-16 Personalis, Inc.
PSNL 		S, Open-market sale 94,218 disposed 26.68 2,513,736.24 Form 4, filing 0000905718-20-001057
2020-10-15 Personalis, Inc.
PSNL 		S, Open-market sale 3,700 disposed 26.32 97,384.00 Form 4, filing 0000905718-20-001051
2020-10-14 Personalis, Inc.
PSNL 		S, Open-market sale 81,925 disposed 27.08 2,218,529.00 Form 4, filing 0000905718-20-001051
2020-10-13 Personalis, Inc.
PSNL 		S, Open-market sale 86,819 disposed 28.43 2,468,264.17 Form 4, filing 0000905718-20-001041
2020-10-12 Personalis, Inc.
PSNL 		S, Open-market sale 115,541 disposed 29.09 3,361,087.69 Form 4, filing 0000905718-20-001041
2020-08-18 Personalis, Inc.
PSNL 		S, Open-market sale 986,842 disposed 19.00 18,749,998.00 Form 4, filing 0000905718-20-000875
2020-06-26 Soleno Therapeutics Inc
SLNO 		P, Open-market purchase 3,333,330 acquired 1.65 5,499,994.50 Form 4, filing 0000905718-20-000722
2019-10-25 Soleno Therapeutics Inc
SLNO 		P, Open-market purchase 2,300,000 acquired 1.20 2,760,000.00 Form 4, filing 0000905718-19-000873
2018-05-07 Sientra, Inc.
SIEN 		P, Open-market purchase 281,482 acquired 13.50 3,800,007.00 Form 4, filing 0000905718-18-000472
2014-10-29 Sientra, Inc.
SIEN 		P, Open-market purchase 495,000 acquired 15.00 7,425,000.00 Form 4, filing 0000905718-14-000723
2014-10-27 Proteon Therapeutics Inc
PRTO 		P, Open-market purchase 950,000 acquired 10.00 9,500,000.00 Form 4, filing 0000905718-14-000703
2012-04-19 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 682,000 disposed 9.66 6,586,346.80 Form 4, filing 0001140361-12-021579
2012-04-19 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 682,000 disposed 9.66 6,586,346.80 Form 4, filing 0001144204-12-022786
2012-04-18 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 1,614,341 disposed 9.60 15,505,583.87 Form 4, filing 0001140361-12-021579
2012-04-18 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 1,614,341 disposed 9.60 15,505,583.87 Form 4, filing 0001144204-12-022786
2012-04-17 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 1,712,000 disposed 9.61 16,454,203.20 Form 4, filing 0001140361-12-021579
2012-04-17 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 1,712,000 disposed 9.61 16,454,203.20 Form 4, filing 0001144204-12-022786
2012-04-03 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 2,300,000 disposed 11.00 25,300,000.00 Form 4, filing 0001140361-12-019608
2011-04-18 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 4,179,174 disposed 14.87 62,143,481.55 Form 4, filing 0001140361-11-022726
2011-03-11 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 2,750,000 disposed 7.50 20,636,000.00 Form 4, filing 0001140361-11-016696
2011-03-08 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 550,000 disposed 7.50 4,125,990.00 Form 4, filing 0001140361-11-015754
2011-03-04 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 100,000 disposed 7.60 760,000.00 Form 4, filing 0001140361-11-015160
2011-03-02 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 1,200,000 disposed 7.70 9,239,040.00 Form 4, filing 0001140361-11-014276
2011-03-01 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 50,000 disposed 7.61 380,485.00 Form 4, filing 0001140361-11-013380
2011-02-28 Amarin Corp Plc\Uk
AMRN 		S, Open-market sale 275,000 disposed 7.92 2,178,137.50 Form 4, filing 0001140361-11-013380

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 8
  • Open-market sale 22
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Abingworth LLP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001397144

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.